Posted at 09:45h
in
News
by KMFSLLP
Output declines at much faster pace than expected
...
Posted at 09:30h
in
News
by KMFSLLP
LONDON, March 9 (Reuters) - The European Union's banking
watchdog set out a "roadmap" on Friday to help plug gaps in how
the rapidly evolving financial technology sector is regulated.
...
Posted at 09:24h
in
News
by KMFSLLP
BEIJING, March 9 (Reuters) - China's insurance industry's
total premium income in January declined 19.9 percent from a
year earlier to 685.2 billion yuan ($108.15 billion), the China
Insurance Regulatory Commission said on Friday.
Posted at 09:02h
in
News
by KMFSLLP
HONG KONG, March 9 (Reuters) - Chinese drug developer Hua
Medicine is planning to raise at least $400 million in an
initial public offering in Hong Kong in the latest in a series
of biotech floats in the city, said people with knowledge of the
matter.
Posted at 09:00h
in
News
by KMFSLLP
* Hang Seng index ends 1.1 pct higher
China Enterprises index HSCE rises 0.8 pct
HSI financial sector sub-index up 0.9 pct
...
Posted at 08:49h
in
News
by KMFSLLP
ZURICH, March 9 (Reuters) - Swiss bank UBS may
switch the group's functional currency to the dollar from Swiss
francs in Switzerland and sterling in London in the second half
of this year, it said in its annual report on Friday.
Posted at 08:46h
in
News
by KMFSLLP
SHANGHAI/BEIJING, March 9 (Reuters) - China's securities
regulator on Friday publishes draft rules to allow foreign
control of Chinese securities firms.
...
Posted at 08:44h
in
News
by KMFSLLP
March 9 (Reuters) - British financial services firm JTC Plc
said on Friday it planned to list its shares on London's main
market at 290 pence each, giving it a market capitalisation of
310 million pounds ($428.4 million).
Posted at 08:40h
in
News
by KMFSLLP
LONDON, March 9 (Reuters) - European shares opened slightly
lower as investors held their nerve after the announcement of
U.S. tariffs and the focus turned to the U.S. jobs report later
on Friday.
Posted at 08:29h
in
News
by KMFSLLP
HONG KONG, March 9 (Reuters) - Chinese drug developer Hua
Medicine is planning to raise at least $400 million in an
initial public offer in Hong Kong in the latest in a series of
biotech floats in the city, said people with knowledge of the
matter.